About
Immunotherapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalSoutheastern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
30
By Phase
PHASE1: 1PHASE2: 1
By Status
RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07049328Lead Sponsor
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
PHASE1Recruiting
30 participants
Started: Aug 16, 2025 · Completed: Dec 15, 2026
NCT05145569Collaborator
Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer
PHASE2Withdrawn
Started: May 10, 2024 · Completed: Jan 31, 2028
Locations (1)
Headquarters
Miramar, FL, United States
Map
Loading map...